Skip to content
Excelsior
About Excelsior Medical
Enterprise Spirit
Development Strategy
Related Company
Overseas Business
Company History
Product Description
Hemodialysis / Plasma Exchange
Blood Bag
Artificial Stoma
Health Appliances
ESG
Investors
Enterprise Recruitment
Contact Us
繁體中文
Investors
Investor Zone
Material Information
Board of Directors
Financial Information
Monthly Revenue
Financial Statements
Shareholder Services
Shareholders’ Meeting
Institutional Investor Conference
Dividend
Stock Quotes
Stock Transfer Agent and Registrar
Contacts
Stakeholders
Investor
Material Information
Announcement on behalf of major subsidiary,Excelsior Asset Management Co., Ltd., regarding BOD Resolution on capital increase by earnings recapitalization
2026-03-06
Announcement on behalf of major subsidiary, Excelsior Asset Management Co., Ltd., regarding Board Meeting Resolution on dividend distribution.
2026-03-06
The Board of Directors approved dividend distribution
2026-03-06
The Board of Directors approved the convening of the 2026 Annual Shareholders’ Meeting.
2026-03-06
The Board of Directors approved 2025 consolidated financial statements.
2026-03-06
Close of subsequent subscription of 2025 new cash capital and release time of related stocks.
2026-03-03
Announcement for the expected date of the Board meeting for the 2025 Financial Reports is 2026/03/06
2026-02-26
Announcement of the Company’s full receipt of cash capital increase in 2025 and the record date of capital increase.
2026-01-29
Announcement of call for payment of share subscriptions for the 2025 cash capital increase
2026-01-23
Announce the record date of 2025 cash capital increase and share subscription schedule (Banks for Fund Collection/Deposit)
2026-01-07
